{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T03:57:34Z","timestamp":1752983854378},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Therapy"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1007\/s12325-008-0003-4","type":"journal-article","created":{"date-parts":[[2008,1,21]],"date-time":"2008-01-21T08:34:33Z","timestamp":1200904473000},"page":"53-58","source":"Crossref","is-referenced-by-count":5,"title":["Manic symptoms probably associated with short-term low-dose quetiapine use"],"prefix":"10.1007","volume":"25","author":[{"given":"Nurper","family":"Erberk-Ozen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,1,17]]},"reference":[{"key":"3_CR1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02244923","volume":"112","author":"C.F. Saller","year":"1993","unstructured":"Saller CF, Salama AI. Seroquel: biochemical profile of a potential atypical antipsychotic. Psychopharmacol. 1993;112:285\u2013292","journal-title":"Psychopharmacol."},{"key":"3_CR2","doi-asserted-by":"crossref","first-page":"649","DOI":"10.4088\/JCP.v61n0910","volume":"61","author":"J.M. Aubry","year":"2000","unstructured":"Aubry JM, Simon AE, Bertschy G. Possible induction of mania and hypomania by olanzapine or risperidone: a critical review of reported cases. J Clin Psychiatry. 2000;61:649\u2013655.","journal-title":"J Clin Psychiatry"},{"key":"3_CR3","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.pnpbp.2005.11.026","volume":"30","author":"P.G. Michalopoulou","year":"2006","unstructured":"Michalopoulou PG, Lykouras L. Manic\/hypomanic symptoms induced by atypical antipsychotics: a review of the reported cases. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:549\u2013564.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3_CR4","volume-title":"Diagnostic and Statistical Manual of Mental Disorders Text Revision. (DSM IV-TR)","author":"American Psychiatric Association.","year":"2005","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders Text Revision. (DSM IV-TR). 4th ed. Washington, DC: American Psychiatric Association; 2005.","edition":"4th ed"},{"issue":"suppl4","key":"3_CR5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1399-5618.2005.00212.x","volume":"7","author":"E. Vieta","year":"2005","unstructured":"Vieta E, Goikolea JM. Atypical antipsychotics: newer options for mania and maintenance therapy. Bipolar Disord. 2005;7 (suppl 4):21\u201333.","journal-title":"Bipolar Disord."},{"key":"3_CR6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0924-9338(02)00675-2","volume":"17","author":"M. Atmaca","year":"2002","unstructured":"Atmaca M, Kuloglu M, Buyukbayram A, et al. Quetiapine-associated and dose-related hypomania in a woman with schizophrenia. Eur Psychiatry. 2002;17:292\u2013293.","journal-title":"Eur Psychiatry"},{"key":"3_CR7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/070674370304800515","volume":"48","author":"B. Biancosino","year":"2003","unstructured":"Biancosino B, Marmai L, Facchi A, et al. Quetiapine may induce mania: a case report. Can J Psychiatry. 2003;48:349\u2013350.","journal-title":"Can J Psychiatry"},{"key":"3_CR8","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.4088\/JCP.v65n1116","volume":"65","author":"F. Rachid","year":"2004","unstructured":"Rachid F, Bertschy G, Bondolfi G, et al. Possible induction of mania or hypomania by atypical antipsychotics: an update review of reported cases. J Clin Psychiatry. 2004;65:1537\u20131545.","journal-title":"J Clin Psychiatry"},{"key":"3_CR9","doi-asserted-by":"crossref","first-page":"544","DOI":"10.4088\/JCP.v66n0420f","volume":"66","author":"I. Galynker","year":"2005","unstructured":"Galynker I, Khan A, Grebchenko Y, et al. Low-dose risperidone and quetiapine as monotherapy for comorbid anxiety and depression [Letter]. J Clin Psychiatry. 2005;66:544.","journal-title":"J Clin Psychiatry"},{"key":"3_CR10","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4088\/JCP.v66n0420b","volume":"66","author":"S.I. Schutters","year":"2005","unstructured":"Schutters SI, van Megen HJ, Westenberg HG. Efficacy of quetiapine in generalized social anxiety disorder: results from an open label study. J Clin Psychiatry. 2005;66:540\u2013542.","journal-title":"J Clin Psychiatry"},{"key":"3_CR11","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.4088\/JCP.v67n0902","volume":"67","author":"K. Gao","year":"2006","unstructured":"Gao K, Muzina D, Gajwani P, et al. Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review. J Clin Psychiatry. 2006;67:1327\u20131340.","journal-title":"J Clin Psychiatry"},{"key":"3_CR12","first-page":"1661","volume-title":"Kaplan and Sadock\u2019s Comprehensive Textbook of Psychiatry","author":"R.M. Post","year":"2005","unstructured":"Post RM, Altshuler LL. Mood disorders: treatment of bipolar disorders. In: ie]Sadock BJ, Sadock VA, eds. Kaplan and Sadock\u2019s Comprehensive Textbook of Psychiatry. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2005:1661\u20131707.","edition":"8th ed."},{"key":"3_CR13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4088\/JCP.v66n0103","volume":"66","author":"J. Leon de","year":"2005","unstructured":"de Leon J, Susce MT, Pan RM, et al. The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuation. J Clin Psychiatry. 2005;66:15\u201327.","journal-title":"J Clin Psychiatry"},{"key":"3_CR14","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1097\/00004714-200204000-00015","volume":"22","author":"S.M. Strakowski","year":"2002","unstructured":"Strakowski SM, Keck PE Jr, Wong YM, et al. The effect of multiple doses of cimetidine on the steady-state pharmacokinetics of quetiapine in men with selected psychotic disorders. J Clin Psychopharmacol. 2002;22:2001\u20132005.","journal-title":"J Clin Psychopharmacol."},{"key":"3_CR15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"C.A. Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239\u2013245.","journal-title":"Clin Pharmacol Ther."}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-008-0003-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-008-0003-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-008-0003-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T03:55:49Z","timestamp":1559447749000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-008-0003-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["3"],"URL":"https:\/\/doi.org\/10.1007\/s12325-008-0003-4","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}